Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Long-Term Debt Repayments (2016 - 2019)

BioCorRx's Long-Term Debt Repayments history spans 7 years, with the latest figure at $1.3 million for Q4 2019.

  • For Q4 2019, Long-Term Debt Repayments changed N/A year-over-year to $1.3 million; the TTM value through Dec 2020 reached $950000.0, changed 0.0%, while the annual FY2019 figure was $675000.0, N/A changed from the prior year.
  • Long-Term Debt Repayments for Q4 2019 was $1.3 million at BioCorRx, up from -$400000.0 in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $1.3 million in Q4 2019 and bottomed at -$400000.0 in Q3 2019.
  • The 4-year median for Long-Term Debt Repayments is $88000.0 (2016), against an average of $198897.7.
  • The largest annual shift saw Long-Term Debt Repayments tumbled 84.52% in 2015 before it soared 2179.02% in 2016.
  • A 4-year view of Long-Term Debt Repayments shows it stood at $82500.0 in 2015, then skyrocketed by 327.77% to $352912.0 in 2016, then crashed by 95.75% to $15000.0 in 2017, then skyrocketed by 8900.0% to $1.3 million in 2019.
  • Per Business Quant, the three most recent readings for BICX's Long-Term Debt Repayments are $1.3 million (Q4 2019), -$400000.0 (Q3 2019), and $15000.0 (Q2 2017).